Updates are available Correction dated 2024-11-07
Click to view Correction: https://doi.org/10.1038/s44321-024-00165-4
-
Authors
Adhikary, Partho Protim https://orcid.org/0000-0002-3755-0810
Idowu, Temilolu https://orcid.org/0000-0003-1583-8562
Tan, Zheng
Hoang, Christopher
Shanta, Selina
Dumbani, Malti
Mappalakayil, Leah https://orcid.org/0009-0009-7418-1215
Awasthi, Bhuwan https://orcid.org/0000-0002-2636-510X
Bermudez, Marcel https://orcid.org/0000-0002-7421-3282
Weiner, January
Beule, Dieter
Wolber, Gerhard
Page, Brent DG https://orcid.org/0000-0002-2101-1329
Hedtrich, Sarah https://orcid.org/0000-0001-6770-3657
-
Funding
Funding for this research was provided by:
Canadian Government | Canadian Institutes of Health Research (AWD-016113 CIHR 2020)
Canadian Government | Natural Sciences and Engineering Research Council of Canada
Michael Smith Health Research BC
Canadian Allergy, Asthma and Immunology Foundation
Sanofi Genzyme Canada
Faculty of Pharmaceutical Sciences, UBC
BC Lung Foundation
Foundation Charité
- License Information
-
More Information
Article History
Received: 9 August 2023
Revised: 21 May 2024
Accepted: 23 May 2024
First Online: 14 June 2024
Change Date: 7 November 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s44321-024-00165-4
Disclosure and competing interests statement
: The authors declare no competing interests. A patent application has been filed for the discovery of BP79. No further competing interests are being declared.
